Auriga Laboratories, Inc. Reports Preliminary Year-End 2006 Gross Revenues And Provides Forecast for Q1 2007

NORCROSS, Ga.--(BUSINESS WIRE)--Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company with products for the treatment of acute respiratory diseases, dermatological conditions, and Xerostomia (dry mouth), reported preliminary, unaudited results for year ending December 31, 2006.